ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review

Gene fusions of EWSR1 with members of the CREB family of transcription factors (CREB1, ATF1, and CREM) have recently been described in exceptional intracranial myxoid mesenchymal tumors. Although this is a known gene fusion found in various mesenchymal tumors, EWSR1 fusion with CREM has only been observed in 3 intracranial myxoid tumors. In this paper, we present 1 such tumor with in-depth histopathological description and long-term follow-up. There is controversy regarding whether these tumors represent a novel entity or simply an intracranial localization of the myxoid variant of angiomatoid fibrous histiocytoma, a rare soft tissue tumor of the extremities. Out of 11 cases mentioned in the literature, the 3 isolated case reports by Dunham et al, Ochalski et al, and Alshareef et al are designated as angiomatoid fibrous histiocytoma, whereas the others are defined as a novel tumoral entity called intracranial myxoid mesenchymal tumor with EWSR1-CREB fusion. We believe the vast morphological and immunohistochemical spectrum of angiomatoid fibrous histiocytoma makes it difficult to dismiss this diagnosis.

[1]  R. Sciot,et al.  Primary myxoid mesenchymal tumour with intracranial location: report of a case with a EWSR1–ATF1 fusion , 2018, Histopathology.

[2]  K. Ligon,et al.  Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? , 2018, Brain pathology.

[3]  C. Antonescu,et al.  EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location , 2017, The American journal of surgical pathology.

[4]  Robin L. Jones,et al.  The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities , 2017, British Journal of Cancer.

[5]  A. Perry,et al.  Intracranial Angiomatoid Fibrous Histiocytoma: Case Report and Literature Review. , 2016, World neurosurgery.

[6]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[7]  C. Fisher,et al.  Angiomatoid fibrous histiocytoma: the current status of pathology and genetics. , 2015, Archives of pathology & laboratory medicine.

[8]  Wenhui Zhang,et al.  Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology. , 2015, International journal of clinical and experimental pathology.

[9]  C. Fletcher,et al.  Myxoid Variant of So-called Angiomatoid “Malignant Fibrous Histiocytoma”: Clinicopathologic Characterization in a Series of 21 Cases , 2014, The American journal of surgical pathology.

[10]  J. Winther,et al.  Quantifying Changes in the Cellular Thiol-Disulfide Status during Differentiation of B Cells into Antibody-Secreting Plasma Cells , 2013, International journal of cell biology.

[11]  M. Paronetto Ewing Sarcoma Protein: A Key Player in Human Cancer , 2013, International journal of cell biology.

[12]  C. Fisher,et al.  Tumors With EWSR1-CREB1 and EWSR1-ATF1 Fusions: The Current Status , 2012, The American journal of surgical pathology.

[13]  J. Engh,et al.  Intracranial angiomatoid fibrous histiocytoma presenting as recurrent multifocal intraparenchymal hemorrhage Case report , 2022 .

[14]  J. Pfeifer,et al.  Primary Intracerebral Angiomatoid Fibrous Histiocytoma: Report of a Case With a t(12;22)(q13;q12) Causing Type 1 Fusion of the EWS and ATF-1 Genes , 2008, The American journal of surgical pathology.

[15]  U. Surti,et al.  EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma , 2007, Genes, chromosomes & cancer.